314 related articles for article (PubMed ID: 30266435)
1. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability.
Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z
Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435
[TBL] [Abstract][Full Text] [Related]
2. The labeling of stem cells by superparamagnetic iron oxide nanoparticles modified with PEG/PVP or PEG/PEI.
Yang G; Ma W; Zhang B; Xie Q
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():384-90. PubMed ID: 26952437
[TBL] [Abstract][Full Text] [Related]
3. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
[TBL] [Abstract][Full Text] [Related]
4. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
5. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging.
Huang H; Xie Q; Kang M; Zhang B; Zhang H; Chen J; Zhai C; Yang D; Jiang B; Wu Y
Nanotechnology; 2009 Sep; 20(36):365101. PubMed ID: 19687538
[TBL] [Abstract][Full Text] [Related]
6. Effects of Iron-Oxide Nanoparticle Surface Chemistry on Uptake Kinetics and Cytotoxicity in CHO-K1 Cells.
Hanot CC; Choi YS; Anani TB; Soundarrajan D; David AE
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729108
[TBL] [Abstract][Full Text] [Related]
7. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles.
Pongrac IM; Pavičić I; Milić M; Brkić Ahmed L; Babič M; Horák D; Vinković Vrček I; Gajović S
Int J Nanomedicine; 2016; 11():1701-15. PubMed ID: 27217748
[TBL] [Abstract][Full Text] [Related]
10. Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging.
You DG; Saravanakumar G; Son S; Han HS; Heo R; Kim K; Kwon IC; Lee JY; Park JH
Carbohydr Polym; 2014 Jan; 101():1225-33. PubMed ID: 24299895
[TBL] [Abstract][Full Text] [Related]
11. Bioevaluation of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with dihexadecyl phosphate (DHP).
Mieloch AA; Żurawek M; Giersig M; Rozwadowska N; Rybka JD
Sci Rep; 2020 Feb; 10(1):2725. PubMed ID: 32066785
[TBL] [Abstract][Full Text] [Related]
12. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
13. Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells.
Pašukonienė V; Mlynska A; Steponkienė S; Poderys V; Matulionytė M; Karabanovas V; Statkutė U; Purvinienė R; Kraśko JA; Jagminas A; Kurtinaitienė M; Strioga M; Rotomskis R
Medicina (Kaunas); 2014; 50(4):237-44. PubMed ID: 25458961
[TBL] [Abstract][Full Text] [Related]
14. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
15. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information.
Fülöp T; Nemes R; Mészáros T; Urbanics R; Kok RJ; Jackman JA; Cho NJ; Storm G; Szebeni J
J Control Release; 2018 Jan; 270():268-274. PubMed ID: 29203414
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
18. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.
Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B
Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928
[TBL] [Abstract][Full Text] [Related]
19. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
[TBL] [Abstract][Full Text] [Related]
20. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
